SynBiotic SE (DUSE:SBX)

SynBiotic SE Statistics

Total Valuation

SynBiotic SE has a market cap or net worth of EUR 15.21 million.

Market Cap	15.21M
Enterprise Value	n/a

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

SynBiotic SE has 6.82 million shares outstanding.

Current Share Class	6.82M
Shares Outstanding	6.82M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.94
PB Ratio	0.99
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.27.

Current Ratio	0.81
Quick Ratio	0.33
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	-1.41
Interest Coverage	-43.09

Financial Efficiency

Return on equity (ROE) is -61.58% and return on invested capital (ROIC) is -22.02%.

Return on Equity (ROE)	-61.58%
Return on Assets (ROA)	-13.92%
Return on Invested Capital (ROIC)	-22.02%
Return on Capital Employed (ROCE)	-31.27%
Weighted Average Cost of Capital (WACC)	5.32%
Revenue Per Employee	70,206
Profits Per Employee	-193,284
Employee Count	55
Asset Turnover	0.10
Inventory Turnover	0.76

Taxes

Income Tax	-134,909
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.67% in the last 52 weeks. The beta is 0.27, so SynBiotic SE's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-42.67%
50-Day Moving Average	4.74
200-Day Moving Average	6.58
Relative Strength Index (RSI)	39.50
Average Volume (20 Days)	250

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SynBiotic SE had revenue of EUR 3.86 million and -10.63 million in losses. Loss per share was -2.24.

Revenue	3.86M
Gross Profit	1.51M
Operating Income	-8.41M
Pretax Income	-11.87M
Net Income	-10.63M
EBITDA	-7.54M
EBIT	-8.41M
Loss Per Share	-2.24

Balance Sheet

The company has 2.07 million in cash and 4.15 million in debt, with a net cash position of -2.08 million or -0.31 per share.

Cash & Cash Equivalents	2.07M
Total Debt	4.15M
Net Cash	-2.08M
Net Cash Per Share	-0.31
Equity (Book Value)	15.33M
Book Value Per Share	3.15
Working Capital	-1.49M

Cash Flow

In the last 12 months, operating cash flow was -2.92 million and capital expenditures -19,181, giving a free cash flow of -2.94 million.

Operating Cash Flow	-2.92M
Capital Expenditures	-19,181
Depreciation & Amortization	868,079
Net Borrowing	-222,676
Free Cash Flow	-2.94M
FCF Per Share	-0.43

Margins

Gross margin is 39.01%, with operating and profit margins of -217.87% and -275.31%.

Gross Margin	39.01%
Operating Margin	-217.87%
Pretax Margin	-307.44%
Profit Margin	-275.31%
EBITDA Margin	-195.39%
EBIT Margin	-217.87%
FCF Margin	n/a

Dividends & Yields

SynBiotic SE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,799.73%
Shareholder Yield	-1,799.73%
Earnings Yield	-69.90%
FCF Yield	-19.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SynBiotic SE has an Altman Z-Score of -1.86 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.86
Piotroski F-Score	1